OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Various strategies can be employed to antibody titer, including process parameter optimization, genetic engineering, and adoption of perfusion technologies. Fine-tuning growth parameters plays